PERCEPTIVE ADVISORS LLC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 2:35 pm Sale |
2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
PERCEPTIVE ADVISORS LLC | 2,191,425 3.800% |
-1,092,358 (-33.27%) |
Filing |
| 2022-02-14 5:33 pm Sale |
2021-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
PERCEPTIVE ADVISORS LLC | 3,283,783 5.900% |
-409,733 (-11.09%) |
Filing |
| 2021-02-16 3:30 pm Purchase |
2020-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
PERCEPTIVE ADVISORS LLC | 3,693,516 7.400% |
490,110 (+15.30%) |
Filing |